NEW JERSEY — Brooklyn Roasting Works LLC has voluntarily recalled more than 1,200 units of its pasteurized cold brew concentrate distributed in New Jersey and New York because improper storage could lead to the formation of botulinum toxin, according to the U.S. Food and Drug Administration.
The recall affects Brooklyn Roasting Company Pasteurized Cold Brew Concentrate sold in 2.5-gallon bag-in-box containers and distributed between April 1 and June 20, 2026.
According to the FDA, the recalled product was stored under ambient conditions, which may allow the formation of Clostridium botulinum toxin, the bacterium that causes botulism, a rare but potentially fatal illness.
The recall includes products with best-by dates ranging from June 30, 2026, through Sept. 30, 2026, and affects 1,219 units.
The company initiated the voluntary recall on July 2, and the FDA classified it as a Class II recall on July 21. A Class II recall is issued when use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or when the probability of serious adverse health consequences is remote.
Consumers and businesses that have the recalled cold brew concentrate should not use the product and should follow instructions provided by Brooklyn Roasting Works or their distributor regarding its return or disposal.
